Mucosal vaccination with recombinant poxvirus vaccines protects ferrets against symptomatic CDV infection.
Mucosal vaccination with recombinant poxvirus vaccines protects ferrets against symptomatic CDV infection.
复制标题
DOI：
10.1016/s0264-410x(98)00211-4
复制
发表时间：
1999-02
期刊：
影响因子：
5.5
通讯作者：
J. Welter;J. Taylor;J. Tartaglia;E. Paoletti;C. Stephensen
中科院分区：
文献类型：
--
作者：
J. Welter;J. Taylor;J. Tartaglia;E. Paoletti;C. Stephensen
Canine distemper virus (CDV) infection of ferrets causes a disease characterized by fever, erythema, conjunctivitis and leukocytopenia, similar clinically to measles except for the fatal neurologic sequelae of CDV. We vaccinated juvenile ferrets twice at 4-week intervals by the intranasal or intraduodenal route with attenuated vaccinia (NYVAC) or canarypox virus (ALVAC) constructs containing the CDV hemagglutinin and fusion genes. Controls were vaccinated with the same vectors expressing rabies glycoprotein. Animals were challenged intranasally 4 weeks after the second vaccination with virulent CDV. Body weights, white blood cell (WBC) counts and temperatures were monitored and ferrets were observed daily for clinical signs of infection. WBCs were assayed for the presence of viral RNA by RT-PCR. Intranasally vaccinated animals survived challenge with no virologic or clinical evidence of infection. Vaccination by the intraduodenal route did not provide complete protection. All control animals developed typical distemper. Ferrets can be effectively protected against distemper by mucosal vaccination with poxvirus vaccines.
